Literature DB >> 3004276

Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin.

J N Wasserheit, T A Bell, N B Kiviat, P Wølner-Hanssen, V Zabriskie, B D Kirby, E C Prince, K K Holmes, W E Stamm, D A Eschenbach.   

Abstract

Thirty-six women with suspected pelvic inflammatory disease were examined by laparoscopy and endometrial biopsy. Acute salpingitis was diagnosed by laparoscopy in 22. Among women with evaluable biopsy samples, plasma cell endometritis was present in 14 of 20 with acute salpingitis and in 1 of 13 without acute salpingitis (p less than 0.001). Chlamydia trachomatis, Neisseria gonorrhoeae, or both were identified in the endometrium or fallopian tubes in 11 of 14 women with both salpingitis and endometritis, in 2 of 9 with salpingitis or endometritis alone, and in 0 of 13 without salpingitis or endometritis (p less than 0.0001). Anaerobic or facultative bacteria or mycoplasmas were isolated from tubes or peritoneum from 9 of 14 women with both salpingitis and endometritis, 2 of 9 with salpingitis or endometritis alone, and 3 of 13 without salpingitis or endometritis. Therapy with clindamycin plus tobramycin produced an adequate short-term clinical response in 16 of 19 patients, although patients with severe salpingitis at laparoscopy responded slowly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004276     DOI: 10.7326/0003-4819-104-2-187

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

Review 1.  Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

Authors:  I Simms; J M Stephenson
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

2.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

Review 3.  Optimum therapy for acute pelvic inflammatory disease.

Authors:  M G Dodson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

4.  Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens.

Authors:  C A Gaydos; C A Reichart; J M Long; L E Welsh; T M Neumann; E W Hook; T C Quinn
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 5.  Nongonococcal urethritis: diagnosis and management.

Authors:  L M Lucas; D L Smith
Journal:  J Gen Intern Med       Date:  1987 May-Jun       Impact factor: 5.128

Review 6.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

Review 7.  Microbiota and pelvic inflammatory disease.

Authors:  Harsha Sharma; Reshef Tal; Natalie A Clark; James H Segars
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

8.  Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.

Authors:  W R Bowie; V Willetts; D W Megran
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

9.  Diagnosis of pelvic inflammatory disease: time for a rethink.

Authors:  I Simms; F Warburton; L Weström
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

10.  Stimulating an immune response? Oral sex is associated with less endometritis.

Authors:  R Pittrof; E Sully; D C Bass; S F Kelsey; R B Ness; C L Haggerty
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.